Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows Post author: Post published:June 4, 2024 Post category:uncategorized Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells. You Might Also Like Python blood compound could lead to new weight loss therapies March 19, 2026 Methotrexate found to be effective alternative to prednisone for pulmonary sarcoidosis May 18, 2025 KFF Health News’ ‘What the Health?’: SCOTUS rejects abortion pill challenge — for now June 13, 2024